But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...

Outlook Therapeutics, Inc. (NASDAQ:OTLK) completed the analysis of the complete 12-week safety and efficacy results for NORSE ...

Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...

A new storage technique can keep protein-based drugs and vaccines stable without keeping them cold. The discovery, led by ...

Drugmaker MSN Pharmaceuticals cleared another hurdle on Thursday toward launching its generic version of Novartis' ...

Sources predict required front-of-pack labeling could mean giving up key real estate in costly redesigns — or, more ...

A Maryland Heights-based manufacturer of drug-delivery devices won a multimillion-dollar federal contract to produce a ...

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

But for all the noise, many Wall Street professionals believe the policy risk in the healthcare sector is lower than feared. ...

At the J.P. Morgan Health Care conference, the future outlook for GLP-1 drugs used to treat obesity was a key focus, ...